Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded
- Contract number
- SPE2DR26FU046
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,259
Award facts
- Contract value 100% obligated
- $1,259.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Actemra Actpen 162 mg/0.9 ml auto-injector pens, with a ceiling value of $1,259.18. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The order is set for ultimate completion by November 21, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company holds a substantial portfolio of competitively awarded contracts with the Defense Logistics Agency covering a comprehensive range of medications and medical supplies across multiple therapeutic domains. The Actemra (tocilizumab) auto-injector pen is a specialty pharmaceutical product used in rheumatoid arthritis treatment, demonstrating the contractor's role in supplying specialized medical commodities to support military personnel and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FU046?
SPE2DR26FU046 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FU046 worth?
The government has obligated $1,259 on SPE2DR26FU046.
Is contract SPE2DR26FU046 an order under another contract?
Yes. SPE2DR26FU046 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU046 competed?
The extent of competition for SPE2DR26FU046 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award